- Does glatiramer acetat belong to first-line treatments of MS2000 | First Faculty of Medicine
- Glatiramer acetate and three case reports2016 | Faculty of Medicine in Hradec Králové
- Glatiramer acetate - mechanisms of anti-inflammatory and neuroprotective actions2014 | Faculty of Medicine in Hradec Králové
- Glatiramer acetate and treatment of multiple sclerosis2015 | Faculty of Medicine in Hradec Králové
- Glatirameracetate - the treatment of multiple sclerosis monitored in the ReMuS Registry2020 | Faculty of Medicine in Pilsen
- Interferon β and glatiramer acetate in the treatment of multiple sclerosis; new insights into their activities2014 | Faculty of Medicine in Hradec Králové
- Glatiramer acetát ve světle nových poznatků2015 | Third Faculty of Medicine
- The importance of early treatment of multiple sclerosis2004 | First Faculty of Medicine
- GALA trial - glatiramer acetate 40 mg three times a week2014 | First Faculty of Medicine
- Long-term effectiveness of glatiramer acetate in clinical practice conditions: XPERIENCIA-5 Study2015 | Publication without faculty affiliation
- Effect of LPG-endermotherapy on skin changes resulting from long-term treatment with glatiramer acetate +12015 | Second Faculty of Medicine
- Current possibilities and principles of pharmacotherapy in relapsing-remitting multiple sclerosis2014 | Publication without faculty affiliation
- Interferons-β treatment during pregnancy and breast-feeding2020 | Second Faculty of Medicine
- Fingolimod in clinical practice: case reports2014 | Publication without faculty affiliation
- Clinically isolated syndrome (CIS) and a treatment by glatiramer acetate2014 | Publication without faculty affiliation
- Monitoring of interferon beta bioactivity in the multiple sclerosis2011 | Second Faculty of Medicine
- Breastfeeding and multiple sclerosis2022 | Second Faculty of Medicine
- Multiple sclerosis +22008 | First Faculty of Medicine
- Pharmacotherapy of multiple sclerosis.1999 | Faculty of Physical Education and Sport
- Pharmacological treatment possibilities in clinically isolated syndrome2009 | First Faculty of Medicine
- Current treatment options in multiple sclerosis2011 | First Faculty of Medicine
- Current therapeutic options for multiple sclerosis2010 | First Faculty of Medicine
- Does the development of new drugs for multiple sclerosis change the prognosis of the patient ?2011 | First Faculty of Medicine
- A comparison of efficacy of subcutaneous interferon beta-1a 44 mu g, dimethyl fumarate and fingolimod in the real-life clinical practise - a multicenter observational study2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Does the development of new drugs for multiple sclerosis change the prognosis of the patient?2011 | First Faculty of Medicine